Children’s hospitals prepare for surge in admissions amid shortage of RSV drug A supply shortage means a drug that can prevent respiratory syncytial virus (RSV) in infants won’t have a major immediate impact, children’s hospitals said, and they are preparing for a… nweixel The Hill

“Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and won’t have as great an impact on volumes this immediate respiratory season,” the Children’s Hospital Association said in a statement.

...

t

EU sets up new mechanisms to stave off medicine shortages The European Commission on Tuesday launched some short-term measures to prevent medicine shortages this winter and the next as a stop-gap while a proposed pharmaceutical rules overhaul is hashed out by the EU's key legislative arms. Julia Payne Reuters

...

Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase | CNN The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday. Meg Tirrell CNN

The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. That’s 2.6 times higher than the $530-per-course price paid by the US government, which provided Paxlovid free to patients during the pandemic. The Wall Street Journal first reported the new price.